NEW YORK (360Dx) – Capitala Group announced today it invested a combination of senior secured debt and equity totaling $19.5 million in Shoreline, Washington-based immunology and allergy testing lab US BioTek Laboratories.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
This webinar will present the utility of a personalized in silico analytical approach for the routine clinical diagnosis of channelopathies and cardiomyopathies.
This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.